CTCBIO Inc. (KOSDAQ:060590)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,190.00
-160.00 (-2.18%)
Feb 19, 2025, 9:00 AM KST
-17.45%
Market Cap 170.71B
Revenue (ttm) 138.95B
Net Income (ttm) -16.79B
Shares Out 23.91M
EPS (ttm) -702.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 64,041
Average Volume 101,822
Open 7,370.00
Previous Close 7,350.00
Day's Range 7,080.00 - 7,370.00
52-Week Range 6,000.00 - 10,500.00
Beta 0.40
RSI 52.10
Earnings Date Mar 20, 2025

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 249
Stock Exchange KOSDAQ
Ticker Symbol 060590
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.